Skip to main content

Primary Biliary Cholangitis clinical trials at UCSF

1 research study open to eligible people

Primary biliary cholangitis is a liver disease that affects bile ducts. UCSF is researching how Seladelpar affects people with this disease and compensated cirrhosis. The study aims to evaluate the drug's impact on health outcomes for these patients.

Showing trials for

Last updated: